Literature DB >> 1633066

Effects of a non-absorbable osmotic load on drug absorption in healthy volunteers.

S A Riley1, M Kim, F Sutcliffe, M Kapas, M Rowland, L A Turnberg.   

Abstract

1. We have studied the effects of a non-absorbable osmotic load on the absorption of a multicomponent solution of frusemide, atenolol, hydrochlorothiazide and salicylic acid in six healthy volunteers. 2. Each subject was studied on up to four separate occasions. The drugs were administered in one of four solutions: a) a mannitol/electrolyte solution, b) a double-strength mannitol/electrolyte solution, c) a glucose/electrolyte solution and d) water. Lactulose or sulphasalazine were added as oro-caecal transit markers. Lactulose was included in the mannitol- and glucose-based solutions, adding a further non-absorbable osmotic load, and sulphasalazine was added to the water, adding little osmotic load. 3. The absorption of atenolol and hydrochlorothiazide was two- to three-times less from all lactulose-containing solutions than from the sulphasalazine-containing solution. The absorption of frusemide and salicylic acid was similar from all four solutions. 4. The largest non-absorbable osmotic load impaired the absorption of atenolol and hydrochlorothiazide most and the incorporation of glucose only partly restored absorption. 5. These results suggest that transmucosal water movement is an important determinant of atenolol and hydrochlorothiazide absorption but is less relevant for the absorption of frusemide and salicylic acid. Furthermore, these data demonstrate a previously unrecognised interaction between a commonly prescribed laxative--lactulose, and atenolol and hydrochlorothiazide.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1633066      PMCID: PMC1381373          DOI: 10.1111/j.1365-2125.1992.tb04105.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  28 in total

Review 1.  The pathophysiology of diarrhoea.

Authors:  L A Turnberg
Journal:  Clin Gastroenterol       Date:  1979-09

2.  Postprandial duodenal function in man.

Authors:  L J Miller; J R Malagelada; V L Go
Journal:  Gut       Date:  1978-08       Impact factor: 23.059

3.  The contribution of solvent drag to the intestinal absorption of the acidic drugs benzoic acid and salicylic acid from the jejunum of the rat.

Authors:  H Ochsenfahrt; D Winne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  The contribution of solvent drag to the intestinal absorption of the basic drugs amidopyrine and antipyrine from the jejunum of the rat.

Authors:  H Ochsenfahrt; D Winne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  A pharmacological method of measuring mouth caecal transit time in man.

Authors:  M Kennedy; P Chinwah; D N Wade
Journal:  Br J Clin Pharmacol       Date:  1979-10       Impact factor: 4.335

6.  Relationship between small bowel transit time and absorption of a solid meal. Influence of metoclopramide, magnesium sulfate, and lactulose.

Authors:  A M Holgate; N W Read
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

7.  Kinetics and absolute bioavailability of atenolol.

Authors:  W D Mason; N Winer; G Kochak; I Cohen; R Bell
Journal:  Clin Pharmacol Ther       Date:  1979-04       Impact factor: 6.875

8.  Brief clinical and laboratory observations.

Authors:  E B Charney; J N Bodurtha
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

9.  Pharmacokinetics of hydrochlorothiazide in man.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

10.  Improvement of medication compliance in uncontrolled hypertension.

Authors:  R B Haynes; D L Sackett; E S Gibson; D W Taylor; B C Hackett; R S Roberts; A L Johnson
Journal:  Lancet       Date:  1976-06-12       Impact factor: 79.321

View more
  9 in total

Review 1.  Impact of osmotically active excipients on bioavailability and bioequivalence of BCS class III drugs.

Authors:  Mei-Ling Chen; Nakissa Sadrieh; Lawrence Yu
Journal:  AAPS J       Date:  2013-07-19       Impact factor: 4.009

2.  The effects of pharmaceutical excipients on small intestinal transit.

Authors:  D A Adkin; S S Davis; R A Sparrow; P D Huckle; A J Phillips; I R Wilding
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

3.  Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine.

Authors:  Abdul W Basit; Fridrun Podczeck; J Michael Newton; Wendy A Waddington; Peter J Ell; Larry F Lacey
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

4.  Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat.

Authors:  H Lennernäs; O Ahrenstedt; A L Ungell
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

Review 5.  A Critical Overview of the Biological Effects of Excipients (Part I): Impact on Gastrointestinal Absorption.

Authors:  Marilyn N Martinez; Balint Sinko; Fang Wu; Talia Flanagan; Enikő Borbás; Eleftheria Tsakalozou; Kathleen M Giacomini
Journal:  AAPS J       Date:  2022-05-02       Impact factor: 4.009

Review 6.  Pharmacokinetic considerations in gastrointestinal motor disorders.

Authors:  G S Hebbard; W M Sun; F Bochner; M Horowitz
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

7.  Concentration-dependent effects of polyethylene glycol 400 on gastrointestinal transit and drug absorption.

Authors:  Julia D R Schulze; Wendy A Waddington; Peter J Eli; Gary E Parsons; Mark D Coffin; Abdul W Basit
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

Review 8.  Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation?

Authors:  H Lennernäs
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

Review 9.  Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches.

Authors:  David Dahlgren; Hans Lennernäs
Journal:  Pharmaceutics       Date:  2019-08-13       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.